Topics

AstraZeneca's immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer http://www.firstwordpharma.com/node/1652638?tsid=28®ion_id=6#axzz5tOBYUG7c …

17:07 EDT 12 Jul 2019 | FirstWord Pharma

AstraZeneca's immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer http://www.firstwordpharma.com/node/1652638?tsid=28&region_id=6#axzz5tOBYUG7c …

Original Article: AstraZeneca's immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer http://www.firstwordpharma.com/node/1652638?tsid=28®ion_id=6#axzz5tOBYUG7c …

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca's immunotherapy Imfinzi granted orphan drug status by FDA for small-cell lung cancer http://www.firstwordpharma.com/node/1652638?tsid=28®ion_id=6#axzz5tOBYUG7c …"

Quick Search

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...